A detailed history of Ethic Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ethic Inc. holds 46,624 shares of EW stock, worth $3.16 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
46,624
Previous 52,555 11.29%
Holding current value
$3.16 Million
Previous $4.85 Million 36.63%
% of portfolio
0.08%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $354,080 - $556,209
-5,931 Reduced 11.29%
46,624 $3.08 Million
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $499,983 - $559,352
5,931 Added 12.72%
52,555 $4.85 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $604,185 - $795,919
8,329 Added 21.75%
46,624 $4.46 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $29,991 - $37,791
486 Added 1.29%
38,295 $2.92 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $156,988 - $211,599
2,266 Added 6.38%
37,809 $2.62 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $2.89 Million - $3.35 Million
35,543 New
35,543 $3.35 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $890,290 - $1.14 Million
-13,035 Reduced 27.1%
35,065 $2.62 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $235,248 - $306,420
-2,856 Reduced 5.6%
48,100 $3.98 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $401,446 - $595,301
4,641 Added 10.02%
50,956 $4.85 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $678,034 - $853,461
6,650 Added 16.77%
46,315 $5.45 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $567,164 - $696,785
5,332 Added 15.53%
39,665 $5.14 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $372,842 - $444,723
3,623 Added 11.8%
34,333 $3.89 Million
Q2 2021

Aug 10, 2021

BUY
$83.84 - $104.76 $593,922 - $742,119
7,084 Added 29.98%
30,710 $3.18 Million
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $522,828 - $602,502
6,645 Added 39.13%
23,626 $1.98 Million
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $407,270 - $518,277
5,681 Added 50.27%
16,981 $1.55 Million
Q3 2020

Oct 27, 2020

BUY
$67.19 - $87.44 $202,510 - $263,544
3,014 Added 36.37%
11,300 $902,000
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $355,194 - $475,012
6,173 Added 292.14%
8,286 $573,000
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $5,922 - $9,153
113 Added 5.65%
2,113 $399,000
Q4 2019

May 22, 2020

BUY
$71.7 - $82.09 $19,287 - $22,082
269 Added 15.54%
2,000 $467,000
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $124,112 - $142,097
1,731 New
1,731 $404,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.